Molecular Mechanisms of Cell Invasion
细胞侵袭的分子机制
基本信息
- 批准号:7500215
- 负责人:
- 金额:$ 21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-25 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This is a proposal to investigate the molecular mechanisms underlying tumor cell invasion. Acquistion of
invasive potential confers on tumor cells the ability to detach from the primary tumor and spread to distal
sites. Using an invasive melanoma cell line as a model system, we have found that the small GTP-binding
protein, ARF6, regulates cell invasion. In recent years, ARF6 has emerged as an important signaling
molecule and has been shown to regulate endosome cycling, and actin remodeling in a variety of cell types,
both of which can impinge on the acquisition of cell migratory/invasive potential. Our studies demonstrate
that ARF6 activation is linked to the activation of ERK via a signaling pathway that appears to be essential
for cell invasion. Silencing of ARF6 by siRNAs or expression of an ARF6 dominant negative mutant
abolishes invasion in cell-based in vitro assays. We have also shown that activation of endogenous ARF6
increases in response to physiological stimuli that stimulate tumor cell invasion. In this application, we aim to
investigate the mechanisms by which ARF6 regulates cell invasion. Based on preliminary findings, we
hypothesize that ARF6 activation promotes tumor cell invasion at least in part, by regulating (1) the
trafficking of metalloproteases and (2) cytoskeletal remodeling required for invadopodia formation. By using
cell biological, molecular and biochemical approaches in both, cell and animal model systems, we will
investigate the role of ARF6 in tumor cell invasion. We propose three specific aims. In aim 1, we will
investigate the role of ARF6 in the regulation of protease traffic by examining its regulation of MT1-MMP
traffic and the release of proteases from the cell surface. In aim 2, we will elucidate the signal transduction
pathway linking ARF6 to Rac1 activation during cell invasion and ask if invadopodia formation is important
for protease secretion. In aim 3, we will investigate the role of the ARF6 GTPase cycle in melanoma cell
invasion in vivo using a mouse model system. We believe that the information gained from investigations
will provide new insights into the regulation of protease trafficking, a relatively understudied area of cancer
biology, and will broaden existing knowledge on the molecular changes that occur during tumor progression.
It is hoped that these findings will ultimately aid in the design of new strategies for diagnostic and/or
therapeutic intervention of cancer progression.
这是一个研究肿瘤细胞侵袭的分子机制的建议。习得
侵袭潜力赋予肿瘤细胞从原发肿瘤分离并扩散到远端的能力
网站.使用侵袭性黑色素瘤细胞系作为模型系统,我们已经发现,
ARF 6蛋白调节细胞侵袭。近年来,ARF 6已成为一种重要的信号,
分子,并已显示在多种细胞类型中调节内体循环和肌动蛋白重塑,
这两者都可能影响细胞迁移/侵入潜能的获得。我们的研究表明
ARF 6的激活通过一个信号通路与ERK的激活有关,
for cell细胞invasion入侵.通过siRNA沉默ARF 6或表达ARF 6显性阴性突变体
在基于细胞的体外测定中消除了侵袭。我们还发现内源性ARF 6的激活
增加对刺激肿瘤细胞侵袭的生理刺激的反应。在本申请中,我们的目标是
研究ARF 6调节细胞侵袭的机制。根据初步调查结果,我们
假设ARF 6激活至少部分地通过调节(1)
金属蛋白酶的运输和(2)侵袭伪足形成所需的细胞骨架重塑。通过使用
细胞生物学,分子和生物化学方法,细胞和动物模型系统,我们将
研究ARF 6在肿瘤细胞侵袭中的作用。我们提出三个具体目标。在目标1中,
通过检测ARF 6对MT 1-MMP的调节,研究其在蛋白酶运输调节中的作用
细胞表面蛋白酶的运输和释放。在目的2中,我们将阐明信号转导
细胞侵袭过程中ARF 6与Rac 1活化的连接途径,并询问侵袭伪足的形成是否重要
用于蛋白酶分泌。在目的3中,我们将研究ARF 6 GT3循环在黑色素瘤细胞中的作用。
使用小鼠模型系统进行体内侵袭。我们相信从调查中获得的信息
将为蛋白酶运输的调节提供新的见解,这是一个相对研究不足的癌症领域。
生物学,并将扩大现有的知识,在肿瘤进展过程中发生的分子变化。
希望这些发现将最终有助于设计新的诊断和/或治疗策略。
癌症进展的治疗干预。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo.
- DOI:10.1158/0008-5472.can-08-1301
- 发表时间:2009-03-15
- 期刊:
- 影响因子:11.2
- 作者:Muralidharan-Chari V;Hoover H;Clancy J;Schweitzer J;Suckow MA;Schroeder V;Castellino FJ;Schorey JS;D'Souza-Schorey C
- 通讯作者:D'Souza-Schorey C
ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles.
- DOI:10.1016/j.cub.2009.09.059
- 发表时间:2009-12-01
- 期刊:
- 影响因子:0
- 作者:Muralidharan-Chari V;Clancy J;Plou C;Romao M;Chavrier P;Raposo G;D'Souza-Schorey C
- 通讯作者:D'Souza-Schorey C
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRISLYN D'SOUZA-SCHOREY其他文献
CRISLYN D'SOUZA-SCHOREY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRISLYN D'SOUZA-SCHOREY', 18)}}的其他基金
New insights into extracellular signal transduction
细胞外信号转导的新见解
- 批准号:
10566506 - 财政年份:2023
- 资助金额:
$ 21万 - 项目类别:
Pro-tumorigenic roles of a VHL isoform in Clear Cell Renal Cell Carcinoma
VHL 亚型在透明细胞肾细胞癌中的促肿瘤作用
- 批准号:
10649049 - 财政年份:2023
- 资助金额:
$ 21万 - 项目类别:
相似海外基金
ENDOPEPTIDASES AFFECT G-PROTEIN COUPLED RECEPTOR SIGNALING AND RESENSITIZATION
内肽酶影响 G 蛋白偶联受体信号传导和再敏化
- 批准号:
8363772 - 财政年份:2011
- 资助金额:
$ 21万 - 项目类别:
Evolutionary considerations of D-aspartyl endopeptidases and its substrates.
D-天冬氨酰内肽酶及其底物的进化考虑。
- 批准号:
23570272 - 财政年份:2011
- 资助金额:
$ 21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ENDOPEPTIDASES AFFECT G-PROTEIN COUPLED RECEPTOR SIGNALING AND RESENSITIZATION
内肽酶影响 G 蛋白偶联受体信号传导和再敏化
- 批准号:
7957404 - 财政年份:2009
- 资助金额:
$ 21万 - 项目类别:
Study on anti. inflammatory action of endopeptidases for prevention and treatment of periodontal diseases
抗研究。
- 批准号:
21592657 - 财政年份:2009
- 资助金额:
$ 21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ENDOPEPTIDASES AFFECT G-PROTEIN COUPLED RECEPTOR SIGNALING AND RESENSITIZATION
内肽酶影响 G 蛋白偶联受体信号传导和再敏化
- 批准号:
7724215 - 财政年份:2008
- 资助金额:
$ 21万 - 项目类别:
Specificity and Function in Neural Endopeptidases
神经内肽酶的特异性和功能
- 批准号:
9904886 - 财政年份:1999
- 资助金额:
$ 21万 - 项目类别:
Standard Grant